[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$f65-g5LTUgHIk8dGZIHhGe2pKpxnfW0g-O4HGxk3yxcs":3,"$fLjSZUTPclTtvrVbuXUlWZSuVFyR7PdMXwvn5ys5Ppks":8,"$fM_Iaxm4igT_c1jwQaXd6Thia-HCqSBR_CIv09Qz8cRg":55,"$fnaROKj_S9m52LcoDUWS-y-SkhNa2gd9t3DdL_EO7ob0":59},{"code":4,"msg":5,"message":6,"data":6,"success":7},401,"认证失败，无法访问系统资源",null,false,{"code":9,"msg":10,"message":6,"data":11,"success":54},200,"操作成功",{"id":12,"specialistId":13,"specialistAssistants":14,"profilePhoto":15,"specialistName":16,"hospital":17,"department":18,"postsTitle":19,"materialTotal":20,"videoTotal":21,"isConcern":7,"title":22,"coverVertical":23,"coverAcross":24,"content":25,"description":26,"views":27,"likes":21,"isThumbsUp":7,"isCollection":7,"collections":21,"createTime":28,"seoTitle":22,"seoKeywords":29,"seoDescription":30,"shelvesTime":31,"version":32,"menus":33,"menuId":35,"type":42,"quality":53,"commentCount":21,"isComment":42},65417,867568,[],"https://ystcdn.venuertc.com/learnMaterial/ystApp//Qwz6GyCWTi4XHRajDQhvP0c86fSiOy65.png","李文旭","温州老年病医院","肿瘤科","主治医师",317,0,"鼻恶性黑色素瘤药品安全用药实用指南","","https://ystcdn.venuertc.com/venue/AI/e51d3f53-6331-4ca9-b609-65964bd25bd8.jpg","\u003Cdiv class=\"melanoma-guide-container\">\n  \u003Ch1 id=\"material_title\" class=\"melanoma-guide-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">鼻恶性黑色素瘤药品安全用药实用指南\u003C/h1>\n  \u003Cdiv class=\"melanoma-guide-lead\">\n    鼻恶性黑色素瘤的治疗，常常需要用到专门的放化疗药物和现代靶向、免疫药物。这些药物怎么用才安全、有效？用起来有哪些细节不能忽视？本篇实用指南，将系统梳理7个关键的用药知识点，包括服用方法、剂量特点、不良反应、储存建议等，帮你科学、安全使用相关药品，规避常见用药风险。🌿\n  \u003C/div>\n\n  \u003C!-- 01 药物分类与成分简介 -->\n  \u003Csection class=\"melanoma-guide-section\" style=\"background:linear-gradient(90deg,#fafbfc 30%,#f2faf4 100%);\">\n    \u003Ch2 class=\"melanoma-guide-section-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">01 药物类型与成分结构\u003C/h2>\n    \u003Cdiv class=\"melanoma-guide-section-body\">\n      鼻恶性黑色素瘤治疗过程中，常用药物类型主要包括：\u003Cbr>\n      \u003Cul class=\"melanoma-guide-ul\">\n        \u003Cli>\u003Cb>化疗药物\u003C/b>：如达卡巴嗪（Dacarbazine）、替莫唑胺（Temozolomide）、顺铂（Cisplatin）等，通常为注射剂型或口服片剂。\u003C/li>\n        \u003Cli>\u003Cb>放疗辅助药物\u003C/b>：以止吐药、白细胞生长因子为主，如昂丹司琼、G-CSF等。\u003C/li>\n        \u003Cli>\u003Cb>分子靶向药物\u003C/b>：被应用于特定突变的患者，如达拉非尼（Dabrafenib）、曲美替尼（Trametinib）；剂型多为口服片。\u003C/li>\n        \u003Cli>\u003Cb>免疫检查点抑制剂\u003C/b>：帕博利珠单抗（Pembrolizumab）、纳武利尤单抗（Nivolumab）、替雷利珠单抗等，均为静脉注射。\u003C/li>\n      \u003C/ul>\n      \u003Cdiv class=\"melanoma-guide-tip\">正确做法：用药前请详细查看药盒，确认成分、规格和批号，勿混淆不同药品。\u003C/div>\n    \u003C/div>\n  \u003C/section>\n\n  \u003C!-- 02 药理机制简析 -->\n  \u003Csection class=\"melanoma-guide-section\" style=\"background:linear-gradient(90deg,#f7fafc 40%,#eaf5fc 100%);\">\n    \u003Ch2 class=\"melanoma-guide-section-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">02 药品如何发挥作用？\u003C/h2>\n    \u003Cdiv class=\"melanoma-guide-section-body\">\n      各类药物作用机制不同，了解原理能帮助安全用药：\u003Cbr>\n      \u003Cul class=\"melanoma-guide-ul\">\n        \u003Cli>☑ \u003Cb>达卡巴嗪、替莫唑胺\u003C/b>：通过抑制DNA合成，使肿瘤细胞无法分裂增殖。\u003C/li>\n        \u003Cli>☑ \u003Cb>顺铂\u003C/b>：与DNA结合并引起损伤，从而干扰细胞复制。\u003C/li>\n        \u003Cli>☑ \u003Cb>达拉非尼、曲美替尼\u003C/b>：阻断肿瘤细胞内MAPK/ERK信号通路，主要用于某些基因突变者。\u003C/li>\n        \u003Cli>☑ \u003Cb>帕博利珠单抗、纳武利尤单抗\u003C/b>：解锁免疫系统“刹车”，增强机体识别并清除异常细胞的能力。\u003C/li>\n      \u003C/ul>\n      \u003Cdiv class=\"melanoma-guide-tip\">注意：作用机制解释帮助分辨药物类别，但具体用法还是要遵医嘱。\u003C/div>\n    \u003C/div>\n  \u003C/section>\n\n  \u003C!-- 03 服用与给药方法细节 -->\n  \u003Csection class=\"melanoma-guide-section\" style=\"background:linear-gradient(90deg,#f9fcfa 40%,#f9f5f2 100%);\">\n    \u003Ch2 class=\"melanoma-guide-section-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">03 服用时间与正确用法\u003C/h2>\n    \u003Cdiv class=\"melanoma-guide-section-body\">\n      \u003Cul class=\"melanoma-guide-ul\">\n        \u003Cli>💊 \u003Cb>达卡巴嗪、顺铂等注射类\u003C/b>通常需在医院静脉滴注。不建议自行注射。\u003C/li>\n        \u003Cli>💊 \u003Cb>替莫唑胺\u003C/b>多为口服胶囊/片剂，每日一次，餐前1小时或餐后2小时，配足量温水整片吞服。\u003C/li>\n        \u003Cli>💊 \u003Cb>分子靶向药物\u003C/b>（达拉非尼等）需按照说明书规定的每日剂量、用法服用。部分药品需餐前空腹服用。\u003C/li>\n        \u003Cli>💉 \u003Cb>免疫抑制剂\u003C/b>由专业医生按疗程静脉输注。\u003C/li>\n      \u003C/ul>\n      \u003Cdiv class=\"melanoma-guide-tip\">给药方式如果更换成口服或静脉，其吸收速度和药效可能有不同，需要留意。\u003C/div>\n      \u003Cdiv class=\"melanoma-guide-case\">案例分享：有一位71岁女性患者，联合放化疗期间服用达卡巴嗪和止吐药，经专业调整，减少了恶心、呕吐的不适发生。\u003C/div>\n    \u003C/div>\n  \u003C/section>\n\n  \u003C!-- 04 剂型特点与服药技巧 -->\n  \u003Csection class=\"melanoma-guide-section\" style=\"background:linear-gradient(90deg,#f2f8fd 40%,#fff 100%);\">\n    \u003Ch2 class=\"melanoma-guide-section-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">04 剂型选择与用药小技巧\u003C/h2>\n    \u003Cdiv class=\"melanoma-guide-section-body\">\n      \u003Cul class=\"melanoma-guide-ul\">\n        \u003Cli>片剂、胶囊：切勿嚼碎或掰开服用，除非说明书允许。\u003C/li>\n        \u003Cli>注射剂型：务必由医疗人员完成，避免自行购入注射。\u003C/li>\n        \u003Cli>长效剂型/控释片：不可擅自破碎或加水溶解。\u003C/li>\n        \u003Cli>抗恶心药如昂丹司琼，最好于化疗前半小时服用，效果更佳。\u003C/li>\n      \u003C/ul>\n      \u003Cdiv class=\"melanoma-guide-tip\">服药时配足量温水，防止药物残留食道或胃部刺激。\u003C/div>\n    \u003C/div>\n  \u003C/section>\n\n  \u003C!-- 05 药物相互作用须知 -->\n  \u003Csection class=\"melanoma-guide-section\" style=\"background:linear-gradient(90deg,#f5fafc 30%,#fcf7fa 100%);\">\n    \u003Ch2 class=\"melanoma-guide-section-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">05 药物相互作用不能忽视\u003C/h2>\n    \u003Cdiv class=\"melanoma-guide-section-body\">\n      \u003Cul class=\"melanoma-guide-ul\">\n        \u003Cli>🍶 部分口服分子靶向药物受葡萄柚汁及某些补品影响，吸收会减少或增加。\u003C/li>\n        \u003Cli>💊 化疗药与其他免疫抑制剂同用时，容易发生感染或血液系统毒性增加。\u003C/li>\n        \u003Cli>☕ 含咖啡因饮品可能与达卡巴嗪增加胃部刺激，宜避开同服。\u003C/li>\n        \u003Cli>💊 避免与具有相似毒性的药物联合，如多种骨髓抑制性的抗肿瘤药拼用。\u003C/li>\n      \u003C/ul>\n      \u003Cdiv class=\"melanoma-guide-tip\">如需同时使用多种药品，务必让医生评估药物搭配，防止叠加毒副作用。\u003C/div>\n    \u003C/div>\n  \u003C/section>\n  \n  \u003C!-- 06 特殊人群用药建议 -->\n  \u003Csection class=\"melanoma-guide-section\" style=\"background:linear-gradient(90deg,#f9faf3 30%,#f8f2fc 100%);\">\n    \u003Ch2 class=\"melanoma-guide-section-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">06 特殊人群的用药调整\u003C/h2>\n    \u003Cdiv class=\"melanoma-guide-section-body\">\n      \u003Cul class=\"melanoma-guide-ul\">\n        \u003Cli>👵 \u003Cb>老年患者\u003C/b>：需根据肝肾功能、体力状况适当减量，治疗期间加强血常规和肝肾监测。\u003C/li>\n        \u003Cli>🤰 \u003Cb>孕妇和哺乳期女性\u003C/b>：绝大多数药物为禁用，已用者应及时告知医师评估风险。\u003C/li>\n        \u003Cli>👶 \u003Cb>儿童与青少年\u003C/b>：用药剂量需根据体重和体表面积精确计算，不得按成人标准直接服药。\u003C/li>\n        \u003Cli>🩺 \u003Cb>肝肾功能不全者\u003C/b>：部分药物代谢、排泄受影响时，需个体化剂量调整。\u003C/li>\n      \u003C/ul>\n      \u003Cdiv class=\"melanoma-guide-case\">一位老年患者在调整顺铂剂量后，出现轻度肾功能异常，经间隔延长和剂量下调后逐步恢复。\u003C/div>\n    \u003C/div>\n  \u003C/section>\n\n  \u003C!-- 07 常见不良反应及应对 -->\n  \u003Csection class=\"melanoma-guide-section\" style=\"background:linear-gradient(90deg,#fcf5f9 20%,#f7faf7 100%);\">\n    \u003Ch2 class=\"melanoma-guide-section-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">07 主要不良反应与处理建议\u003C/h2>\n    \u003Cdiv class=\"melanoma-guide-section-body\">\n      不同药品不良反应表现差异较大，常见如下：\u003Cbr>\n      \u003Cul class=\"melanoma-guide-ul\">\n        \u003Cli>\u003Cb>达卡巴嗪、顺铂等化疗药\u003C/b>：恶心、呕吐、白细胞减少、肝肾功能损害。\u003C/li>\n        \u003Cli>\u003Cb>替莫唑胺\u003C/b>：食欲减退、头痛、乏力、骨髓抑制。\u003C/li>\n        \u003Cli>\u003Cb>分子靶向药\u003C/b>：皮疹、发热、关节痛、肝功能异常。\u003C/li>\n        \u003Cli>\u003Cb>免疫检查点抑制剂\u003C/b>：皮疹、皮肤瘙痒、肺炎（免疫相关）、肠炎等。\u003C/li>\n      \u003C/ul>\n      \u003Cdiv class=\"melanoma-guide-tip\">正确做法：出现持续发热、剧烈呕吐、皮疹、呼吸困难、无法进食等异常，需及时联系医生处理。\u003C/div>\n      \u003Cdiv class=\"melanoma-guide-case\">临床上联合帕博利珠单抗治疗时，约15%患者会有皮疹，但大多为轻度，个别需要短暂暂停用药。\u003C/div>\n    \u003C/div>\n  \u003C/section>\n\n  \u003C!-- 08 储存条件及过期处理 -->\n  \u003Csection class=\"melanoma-guide-section\" style=\"background:linear-gradient(90deg,#fafcfa 30%,#f2f8fa 100%);\">\n    \u003Ch2 class=\"melanoma-guide-section-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">08 储存&有效期管理\u003C/h2>\n    \u003Cdiv class=\"melanoma-guide-section-body\">\n      \u003Cul class=\"melanoma-guide-ul\">\n        \u003Cli>所有注射剂、口服片剂应避光、密封、常温下保存（多数为15-25℃）。\u003C/li>\n        \u003Cli>部分药品（如达卡巴嗪冻干粉）需冷藏（2-8℃），不可冷冻。\u003C/li>\n        \u003Cli>开封后药品最长保存7-10天，逾期不用应弃置。\u003C/li>\n        \u003Cli>过期药品请送正规药房或医疗单位，勿自行丢弃。\u003C/li>\n      \u003C/ul>\n      \u003Cdiv class=\"melanoma-guide-tip\">家庭保存时可用小锁药箱，避免儿童接触或湿气污染。\u003C/div>\n    \u003C/div>\n  \u003C/section>\n\n  \u003C!-- 09 漏服与过量补救措施 -->\n  \u003Csection class=\"melanoma-guide-section\" style=\"background:linear-gradient(90deg,#f5fafa 30%,#fcfaf2 100%);\">\n    \u003Ch2 class=\"melanoma-guide-section-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">09 忘记用药、过量后的正确处理\u003C/h2>\n    \u003Cdiv class=\"melanoma-guide-section-body\">\n      \u003Cul class=\"melanoma-guide-ul\">\n        \u003Cli>\u003Cb>如偶尔漏服一剂\u003C/b>：尽快补上，若接近下次用药时，则跳过不补。\u003C/li>\n        \u003Cli>\u003Cb>连续漏服\u003C/b>：不可以一次性大量补服，请直接恢复正常节奏。\u003C/li>\n        \u003Cli>\u003Cb>服药过量\u003C/b>：若短时间大量服药或注射后出现不适，应立刻就医，保留药品外包装协助医生判断。\u003C/li>\n        \u003Cli>\u003Cb>静脉制剂溢出\u003C/b>：局部可能出现疼痛、肿胀，应及时告知医护人员处理。\u003C/li>\n      \u003C/ul>\n      \u003Cdiv class=\"melanoma-guide-tip\">所有异常情况，勿随意自处理，也不可自行用解毒药品替代。\u003C/div>\n    \u003C/div>\n  \u003C/section>\n\n  \u003C!-- 10 数据与文献支撑 -->\n  \u003Csection class=\"melanoma-guide-section\" style=\"background:linear-gradient(90deg,#fafcf2 30%,#f2fcfa 100%);\">\n    \u003Ch2 class=\"melanoma-guide-section-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">10 权威数据与文献引证\u003C/h2>\n    \u003Cdiv class=\"melanoma-guide-section-body\">\n      \u003Cul class=\"melanoma-guide-ul\">\n        \u003Cli>免疫检查点抑制剂（PD-1抗体）在局部晚期/转移性黑色素瘤中客观缓解率约35-45%（Robert C, et al., 2015, N Engl J Med）。\u003C/li>\n        \u003Cli>化疗药物相关骨髓抑制的发生率（如严重白细胞减少）在不同方案中为20-40%（Eggermont AMM, et al., 2021, Cancer Treat Rev）。\u003C/li>\n        \u003Cli>常见皮疹在PD-1/PD-L1接合剂使用期间为10-20%（Postow MA, et al., 2018, JAMA Oncol）。\u003C/li>\n      \u003C/ul>\n      \u003Cdiv class=\"melanoma-guide-tip\">更多药品说明与数据参见官方药品说明书及以下文献：\u003C/div>\n      \u003Cul class=\"melanoma-guide-ref-ul\">\n        \u003Cli>Robert, C., Schachter, J., Long, G. V., et al. (2015). Pembrolizumab versus Ipilimumab in Advanced Melanoma. \u003Ci>New England Journal of Medicine\u003C/i>, 372(26), 2521–2532. \u003Cb>APA引用\u003C/b>\u003C/li>\n        \u003Cli>Eggermont, A. M. M., et al. (2021). Adjuvant and neoadjuvant immunotherapy in melanoma. \u003Ci>Cancer Treatment Reviews\u003C/i>, 98, 102238. \u003Cb>APA引用\u003C/b>\u003C/li>\n        \u003Cli>Postow, M. A., Sidlow, R., & Hellmann, M. D. (2018). Immune-Related Adverse Events Associated with Immune Checkpoint Blockade. \u003Ci>JAMA Oncology\u003C/i>, 4(1), 79–85. \u003Cb>APA引用\u003C/b>\u003C/li>\u003C/ul>\u003C/div>\u003C/section>\n\u003C/div>\n\n\u003Cstyle>\n.melanoma-guide-container {\n  font-family: 'Helvetica Neue', Arial, 'PingFang SC', 'Microsoft YaHei', sans-serif;\n  color: #23282c;\n  background: #f5f7fa;\n  padding: 28px 16px 40px 16px;\n  max-width: 790px;\n  margin: auto;\n}\n.melanoma-guide-title {\n  font-size: 2.2rem;\n  font-weight: bold;\n  color: #163243;\n  text-align: center;\n  letter-spacing: 1px;\n  margin-top: 10px;\n  margin-bottom: 29px;\n  padding-bottom: 12px;\n  border-bottom: 3px solid #c7e0e2;\n}\n.melanoma-guide-lead {\n  margin: 0 auto 33px auto;\n  padding: 14px 24px;\n  background: #e8f0f4;\n  color: #245a69;\n  font-size: 1.05rem;\n  border-radius: 10px;\n  border-left: 7px solid #6fc1d7;\n  box-sizing: border-box;\n  line-height: 1.7;\n  font-weight: 500;\n}\n.melanoma-guide-section {\n  margin: 32px 0 24px 0;\n  border-radius: 13px;\n  box-shadow: 0px 2px 19px 0px #f1f4f7;\n  padding: 18px 18px 18px 22px;\n}\n.melanoma-guide-section-title {\n  font-size: 1.28rem;\n  font-weight: bold;\n  color: #23527c;\n  margin-bottom: 15px;\n  letter-spacing: 0.5px;\n  display: flex;\n  align-items: center;\n  gap: 10px;\n  padding-left: 2px;\n}\n.melanoma-guide-section-title:before {\n  content: \"💡\";\n  font-size: 1.1em;\n  margin-right: 7px;\n  vertical-align: middle;\n}\n.melanoma-guide-section-body {\n  font-size: 1.05rem;\n  color: #23383f;\n  line-height: 1.88;\n  padding-right: 4px;\n}\n.melanoma-guide-ul {\n  list-style: disc inside;\n  margin: 12px 0 18px 0;\n  padding-left: 2px;\n}\n.melanoma-guide-ul li {\n  padding-left: 0;\n  margin-bottom: 6px;\n  line-height: 1.8;\n}\n.melanoma-guide-tip {\n  background: #ffffe8;\n  color: #896a12;\n  padding: 8px 15px;\n  border-left: 5px solid #edd28b;\n  border-radius: 7px;\n  font-size: 0.99rem;\n  margin-top: 6px;\n  margin-bottom: 0;\n  word-break: break-all;\n}\n.melanoma-guide-case {\n  background: #e9e9fc;\n  color: #3a306b;\n  padding: 8px 15px;\n  border-left: 6px solid #8888ce;\n  border-radius: 7px;\n  font-size: 1.00rem;\n  margin: 10px 0 0 0;\n}\n.melanoma-guide-ref-ul {\n  list-style: square inside;\n  margin: 9px 0 9px 5px;\n  font-size: 0.97rem;\n  color: #215669;\n  word-break: break-all;\n}\n.melanoma-guide-footer {\n  margin-top: 48px;\n  padding: 22px 16px 14px 16px;\n  background: linear-gradient(90deg,#e2faff 30%,#f6fffa 100%);\n  border-radius: 9px;\n  color: #284850;\n  font-size: 1.08rem;\n}\n.melanoma-guide-footer-em {\n  margin-top: 14px;\n  background: #ffeccb;\n  color: #7b4408;\n  padding: 9px 12px;\n  border-radius: 6px;\n  font-size: 1.00rem;\n  font-weight: 600;\n  border-left: 4px solid #fac670;\n  letter-spacing: 0.03em;\n}\n@media (max-width: 600px) {\n  .melanoma-guide-container {\n    padding: 8px 2px;\n  }\n  .melanoma-guide-section {\n    padding: 13px 6px 13px 8px;\n  }\n}\n\u003C/style>\n\n","\u003Cdiv class=\"melanoma-guide-container\">\n  \u003Ch1 id=\"material_title\" class=\"melanoma-guide-title\" style=",517,"2025-09-02 09:16:29","鼻恶性黑色素瘤, 化疗药物, 靶向药物, 安全用药, 药物不良反应, 免疫检查点抑制剂, 用药指南, 药物相互作用","本指南系统梳理鼻恶性黑色素瘤治疗中的药品安全用药知识，包括服用方法、剂量特点及不良反应，帮助患者科学、有效地使用药物，降低用药风险。","2025-09-07 19:30:00",2,[34],{"menuId":35,"menuName":36,"parentId":21,"orderNum":32,"path":37,"component":38,"isFrame":39,"isCache":40,"menuType":41,"visible":42,"status":21,"createDept":6,"remark":23,"createTime":43,"children":44,"columnImage":45,"columnLogo":46,"uncheckedLogo":6,"checkedLogo":6,"isHot":42,"isHome":21,"forceLogin":21,"color":47,"seoTitle":48,"seoKeywords":49,"seoDescription":50,"contentNum":6,"promotionalPoster":51,"menuFrame":7,"innerLink":7,"parentView":7,"routeName":52,"routerPath":37,"componentInfo":38},"1986713082609147906","健康科普","article","/article.html","1","0","T",1,"2025-11-07 16:31:25",[],"https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:49/d4291d16-ed1c-48dd-84c8-ec1f85980b75.png","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:52/6fe64094-9416-442c-a66d-032fb292666a.png","#c8e6ca","健康科普助力健康中国2030:共享健康知识新理念","健康科普, 健康中国, 科普知识, 健康家庭, 性健康, 营养健康, 运动健康, 科普宣传","探索健康科普在健康中国行动中的重要角色,了解最新的健康科普创新大赛、动漫及短视频,传播健康知识,助力全民健康。","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:56/bd33f471-6c54-4d1b-a364-b06973dbc144.png","Article","癌症肿瘤",true,{"code":9,"msg":10,"message":6,"data":56,"success":54},{"pageNo":42,"pageSize":57,"result":58,"totalSize":21},10,[],{"code":9,"msg":10,"message":6,"data":60,"success":54},{"authors":61,"appraiseDimensionScoresVos":62},[],[]]